MASS
908 Devices Inc.
Price Chart
Latest Quote
$10.71
| Previous Close | $10.67 |
| Open | $10.56 |
| Day High | $10.87 |
| Day Low | $10.50 |
| Volume | 137,106 |
Stock Information
| Shares Outstanding | 41.33M |
| Total Debt | $4.30M |
| Cash Equivalents | $101.53M |
| Revenue | $60.84M |
| Net Income | $-34.38M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $442.89M |
| EPS (TTM) | $-0.93 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $343.80M |
| Sales | $60.84M |
| Income | $-34.38M |
| Book/sh | $3.59 |
| Cash/sh | $2.46 |
| Employees | 172 |
Financial Ratios
| Quick Ratio | 2.29 |
| Current Ratio | 2.67 |
| Debt/Eq | 3.39 |
Returns & Margins
| ROA | -6.81% |
| ROE | -24.95% |
| Gross Margin | 52.65% |
| Operating Margin | -39.61% |
| Profit Margin | -56.96% |
Ownership
| Insider Ownership | 7.46% |
| Institutional Ownership | 83.82% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -35.72 |
| P/S | 7.28 |
| P/B | 2.99 |
Analyst Data
| Recommendation | none |
| Target Price | $13.00 |
Technical Indicators
| SMA20 | $9.97 |
| SMA50 | $8.79 |
| SMA200 | $7.19 |
| RSI | 60.86 |
| ATR | 0.5994 |
| Shares Float | 28.03M |
| Short Float | 13.15% |
| Short Ratio | 6.86 |
| Volatility | 0.63 |
| Rel Volume | 0.26 |
Performance History
| Week | -1.88% |
| Month | +33.77% |
| Quarter | +24.16% |
| 6 Months | +62.10% |
| YTD | +110.51% |
| Year | +71.17% |
| 3 Years | +52.20% |
| 5 Years | -67.71% |
| 10 Years | -78.13% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-09-01 | $10.72 | 137,106 |
| 2026-08-31 | $10.67 | 246,200 |
| 2026-08-27 | $11.10 | 502,800 |
| 2026-08-26 | $10.37 | 461,200 |
| 2026-08-25 | $11.00 | 444,100 |
| 2026-08-24 | $10.92 | 723,700 |
| 2026-08-21 | $10.68 | 528,300 |
| 2026-08-20 | $10.35 | 700,100 |
| 2026-08-19 | $10.24 | 655,800 |
| 2026-08-18 | $10.08 | 355,900 |
| 2026-08-17 | $10.19 | 464,800 |
| 2026-08-14 | $10.01 | 645,500 |
| 2026-08-13 | $10.11 | 518,700 |
| 2026-08-12 | $10.02 | 858,400 |
| 2026-08-11 | $10.01 | 1,620,100 |
| 2026-08-10 | $8.80 | 350,000 |
| 2026-08-07 | $8.88 | 322,900 |
| 2026-08-06 | $8.30 | 243,100 |
| 2026-08-05 | $8.41 | 248,900 |
| 2026-08-04 | $8.45 | 443,200 |
| 2026-08-03 | $8.42 | 331,800 |
About 908 Devices Inc.
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
đ° Latest News
908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates
MarketBeat âĸ 2026-08-30T02:01:57Z
908 Devices (MASS) Q2 2026 Earnings Call Transcript
Motley Fool âĸ 2026-08-18T15:44:41Z
TG Therapeutics Conference: 908 Devices Bets on Handheld Drug, Chemical Detection
MarketBeat âĸ 2026-08-18T02:02:13Z
908 Devices Eyes Growth in Handheld Drug and Chemical Detection Market
MarketBeat âĸ 2026-08-15T07:01:58Z
908 Devices Inc (MASS) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ...
GuruFocus.com âĸ 2026-08-13T01:10:05Z908 Devices Inc. Q2 2026 Earnings Call Summary
Moby âĸ 2026-08-12T02:42:24Z
908 Devices Q2 Earnings Call Highlights
MarketBeat âĸ 2026-08-11T15:05:25Z
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates
Zacks âĸ 2026-08-11T12:15:02ZTactile Systems Technology (TCMD) Beats Q2 Earnings and Revenue Estimates
Zacks âĸ 2026-08-10T21:55:09ZRapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates
Zacks âĸ 2026-08-07T12:20:03ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $27,774,000 | $23,246,000 | $24,907,000 | $20,829,000 |
| Cost Of Revenue | $27,774,000 | $23,246,000 | $24,907,000 | $20,829,000 |
| Total Revenue | $56,197,000 | $47,746,000 | $50,229,000 | $46,852,000 |
| Operating Revenue | $56,197,000 | $47,746,000 | $50,229,000 | $46,852,000 |
| Expenses | ||||
| Total Expenses | $81,877,000 | $77,696,000 | $92,880,000 | $82,234,000 |
| Other Income Expense | $-11,799,000 | $-27,684,000 | $-238,000 | $-83,000 |
| Other Non Operating Income Expenses | $1,942,000 | $-241,000 | $-131,000 | $-83,000 |
| Net Non Operating Interest Income Expense | $4,136,000 | $4,494,000 | $6,279,000 | $1,902,000 |
| Operating Expense | $54,103,000 | $54,450,000 | $67,973,000 | $61,405,000 |
| Interest Expense | - | $0 | $201,000 | $129,000 |
| Interest Expense Non Operating | - | $0 | $201,000 | $129,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-33,277,000 | $-53,140,000 | $-36,399,000 | $-33,563,000 |
| Net Interest Income | $4,136,000 | $4,494,000 | $6,279,000 | $1,902,000 |
| Interest Income | $4,136,000 | $4,494,000 | $6,480,000 | $2,031,000 |
| Normalized Income | $-19,563,482 | $-25,751,886 | $-36,292,642 | $-33,563,000 |
| Net Income From Continuing And Discontinued Operation | $19,489,000 | $-72,206,000 | $-36,399,000 | $-33,563,000 |
| Total Operating Income As Reported | $-39,421,000 | $-57,393,000 | $-42,758,000 | $-35,382,000 |
| Net Income Common Stockholders | $19,489,000 | $-72,206,000 | $-36,399,000 | $-33,563,000 |
| Net Income | $19,489,000 | $-72,206,000 | $-36,399,000 | $-33,563,000 |
| Net Income Including Noncontrolling Interests | $19,489,000 | $-72,206,000 | $-36,399,000 | $-33,563,000 |
| Net Income Discontinuous Operations | $52,766,000 | $-19,066,000 | - | - |
| Net Income Continuous Operations | $-33,277,000 | $-53,140,000 | $-36,399,000 | $-33,563,000 |
| Pretax Income | $-33,343,000 | $-53,140,000 | $-36,610,000 | $-33,563,000 |
| Special Income Charges | $-13,741,000 | $-27,443,000 | $-107,000 | - |
| Interest Income Non Operating | $4,136,000 | $4,494,000 | $6,480,000 | $2,031,000 |
| Operating Income | $-25,680,000 | $-29,950,000 | $-42,651,000 | $-35,382,000 |
| Gross Profit | $28,423,000 | $24,500,000 | $25,322,000 | $26,023,000 |
| Per Share | ||||
| Diluted EPS | $0.54 | $-2.12 | $-1.13 | $-1.07 |
| Basic EPS | $0.54 | $-2.12 | $-1.13 | $-1.07 |
| Other | ||||
| Tax Effect Of Unusual Items | $-27,482 | $-54,886 | $-642 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-7,474,000 | $2,175,000 | $-33,918,000 | $-31,820,000 |
| Total Unusual Items | $-13,741,000 | $-27,443,000 | $-107,000 | - |
| Total Unusual Items Excluding Goodwill | $-13,741,000 | $-27,443,000 | $-107,000 | - |
| Reconciled Depreciation | $4,465,000 | $4,682,000 | $2,384,000 | $1,614,000 |
| EBITDA (Bullshit earnings) | $-21,215,000 | $-25,268,000 | $-34,025,000 | $-31,820,000 |
| EBIT | $-25,680,000 | $-29,950,000 | $-36,409,000 | $-33,434,000 |
| Diluted Average Shares | $35,898,542 | $34,076,321 | $32,239,394 | $31,492,531 |
| Basic Average Shares | $35,898,542 | $34,076,321 | $32,239,394 | $31,492,531 |
| Diluted NI Availto Com Stockholders | $19,489,000 | $-72,206,000 | $-36,399,000 | $-33,563,000 |
| Tax Provision | $-66,000 | $0 | $-211,000 | $0 |
| Impairment Of Capital Assets | $0 | $40,659,000 | $0 | - |
| Restructuring And Mergern Acquisition | $13,741,000 | $-13,216,000 | $107,000 | - |
| Research And Development | $15,575,000 | $14,988,000 | $21,904,000 | $17,526,000 |
| Selling General And Administration | $38,528,000 | $39,462,000 | $46,069,000 | $43,879,000 |
| Otherunder Preferred Stock Dividend | - | - | - | - |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $107,287,000 | $75,913,000 | $147,264,000 | $172,061,000 |
| Total Assets | $190,071,000 | $159,476,000 | $202,981,000 | $242,587,000 |
| Total Non Current Assets | $45,512,000 | $56,421,000 | $29,191,000 | $26,961,000 |
| Other Non Current Assets | $471,000 | $12,305,000 | $1,389,000 | $1,384,000 |
| Goodwill And Other Intangible Assets | $36,412,000 | $38,679,000 | $18,227,000 | $18,538,000 |
| Other Intangible Assets | $36,412,000 | $38,679,000 | $7,860,000 | $8,488,000 |
| Current Assets | $144,559,000 | $103,055,000 | $173,790,000 | $215,626,000 |
| Other Current Assets | $7,272,000 | $4,184,000 | $4,181,000 | $4,658,000 |
| Assets Held For Sale Current | $0 | $10,210,000 | - | - |
| Inventory | $12,990,000 | $10,886,000 | $14,938,000 | $12,513,000 |
| Receivables | $11,327,000 | $8,852,000 | $8,989,000 | $10,033,000 |
| Accounts Receivable | $11,327,000 | $8,852,000 | $8,989,000 | $10,033,000 |
| Allowance For Doubtful Accounts Receivable | $-147,000 | $-524,000 | $-395,000 | $-25,000 |
| Gross Accounts Receivable | $11,474,000 | $9,376,000 | $9,384,000 | $10,058,000 |
| Cash Cash Equivalents And Short Term Investments | $112,970,000 | $68,923,000 | $145,682,000 | $188,422,000 |
| Cash And Cash Equivalents | $70,517,000 | $43,355,000 | $121,041,000 | $188,422,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $4,628,000 | $4,073,000 | $5,945,000 | $19,508,000 |
| Long Term Debt And Capital Lease Obligation | $3,947,000 | $2,600,000 | $3,929,000 | $18,040,000 |
| Current Debt And Capital Lease Obligation | $681,000 | $1,473,000 | $2,016,000 | $1,468,000 |
| Long Term Debt | - | - | - | $15,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $46,372,000 | $44,884,000 | $37,490,000 | $51,988,000 |
| Total Non Current Liabilities Net Minority Interest | $12,308,000 | $19,735,000 | $14,941,000 | $32,762,000 |
| Other Non Current Liabilities | $30,000 | $2,284,000 | - | $555,000 |
| Liabilities Heldfor Sale Non Current | $0 | $4,638,000 | - | - |
| Non Current Deferred Liabilities | $8,331,000 | $10,213,000 | $11,012,000 | $14,167,000 |
| Current Liabilities | $34,064,000 | $25,149,000 | $22,549,000 | $19,226,000 |
| Other Current Liabilities | $16,025,000 | $4,696,000 | - | $1,243,000 |
| Current Deferred Liabilities | $8,934,000 | $10,417,000 | $10,629,000 | $7,514,000 |
| Payables And Accrued Expenses | $3,547,000 | $3,419,000 | $3,910,000 | $5,335,000 |
| Payables | $1,586,000 | $1,368,000 | $1,191,000 | $1,397,000 |
| Accounts Payable | $1,586,000 | $1,368,000 | $1,191,000 | $1,397,000 |
| Non Current Deferred Taxes Liabilities | - | $2,030,000 | $2,441,000 | $2,671,000 |
| Equity | ||||
| Common Stock Equity | $143,699,000 | $114,592,000 | $165,491,000 | $190,599,000 |
| Total Equity Gross Minority Interest | $143,699,000 | $114,592,000 | $165,491,000 | $190,599,000 |
| Stockholders Equity | $143,699,000 | $114,592,000 | $165,491,000 | $190,599,000 |
| Gains Losses Not Affecting Retained Earnings | $54,000 | $1,146,000 | $1,365,000 | $798,000 |
| Other Equity Adjustments | $54,000 | $1,146,000 | $1,365,000 | $798,000 |
| Retained Earnings | $-223,316,000 | $-242,805,000 | $-170,599,000 | $-134,200,000 |
| Other | ||||
| Ordinary Shares Number | $36,321,866 | $35,098,493 | $32,519,023 | $31,859,847 |
| Share Issued | $36,321,866 | $35,098,493 | $32,519,023 | $31,859,847 |
| Tangible Book Value | $107,287,000 | $75,913,000 | $147,264,000 | $172,061,000 |
| Invested Capital | $143,699,000 | $114,592,000 | $165,491,000 | $205,599,000 |
| Working Capital | $110,495,000 | $77,906,000 | $151,241,000 | $196,400,000 |
| Capital Lease Obligations | $4,628,000 | $4,073,000 | $5,945,000 | $4,508,000 |
| Total Capitalization | $143,699,000 | $114,592,000 | $165,491,000 | $205,599,000 |
| Additional Paid In Capital | $366,925,000 | $356,216,000 | $334,692,000 | $323,969,000 |
| Capital Stock | $36,000 | $35,000 | $33,000 | $32,000 |
| Common Stock | $36,000 | $35,000 | $33,000 | $32,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $8,331,000 | $10,213,000 | $8,571,000 | $11,496,000 |
| Long Term Capital Lease Obligation | $3,947,000 | $2,600,000 | $3,929,000 | $3,040,000 |
| Current Deferred Revenue | $8,934,000 | $10,417,000 | $10,629,000 | $7,514,000 |
| Current Capital Lease Obligation | $681,000 | $1,473,000 | $2,016,000 | $1,468,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $4,877,000 | $5,144,000 | $5,994,000 | $4,909,000 |
| Current Accrued Expenses | $1,961,000 | $2,051,000 | $2,719,000 | $3,938,000 |
| Net PPE | $8,629,000 | $5,437,000 | $9,575,000 | $7,039,000 |
| Accumulated Depreciation | $-4,408,000 | $-3,553,000 | $-5,947,000 | $-4,717,000 |
| Gross PPE | $13,037,000 | $8,990,000 | $15,522,000 | $11,756,000 |
| Leases | $763,000 | $477,000 | $395,000 | $21,000 |
| Construction In Progress | $0 | $41,000 | $53,000 | $757,000 |
| Other Properties | $9,477,000 | $7,654,000 | $14,500,000 | $10,598,000 |
| Machinery Furniture Equipment | $2,797,000 | $818,000 | $574,000 | $380,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $2,442,000 | $2,165,000 | $1,927,000 | $1,448,000 |
| Work In Process | $988,000 | $1,355,000 | $1,717,000 | $2,722,000 |
| Raw Materials | $9,560,000 | $7,366,000 | $11,294,000 | $8,343,000 |
| Other Short Term Investments | $42,453,000 | $25,568,000 | $24,641,000 | $0 |
| Goodwill | - | $0 | $10,367,000 | $10,050,000 |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-24,643,000 | $-30,849,000 | $-27,104,000 | $-22,975,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-23,688,000 | $-30,247,000 | $-25,059,000 | $-20,930,000 |
| Cash Flow From Continuing Operating Activities | $-23,688,000 | $-30,247,000 | $-25,059,000 | $-20,930,000 |
| Operating Gains Losses | $-55,807,000 | $54,000 | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-955,000 | $-602,000 | $-2,045,000 | $-2,045,000 |
| Investing Cash Flow | $50,747,000 | $-46,321,000 | $-26,400,000 | $-15,807,000 |
| Cash Flow From Continuing Investing Activities | $50,747,000 | $-46,321,000 | $-26,400,000 | $-15,807,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $864,000 | $1,146,000 | $936,000 | $1,553,000 |
| Financing Cash Flow | $-697,000 | $-376,000 | $-15,935,000 | $1,179,000 |
| Cash Flow From Continuing Financing Activities | $-697,000 | $-376,000 | $-15,935,000 | $1,179,000 |
| Net Other Financing Charges | $-1,561,000 | $-1,522,000 | $-1,871,000 | $-374,000 |
| Net Common Stock Issuance | $864,000 | $1,146,000 | $936,000 | $1,553,000 |
| Common Stock Issuance | $864,000 | $1,146,000 | $936,000 | $1,553,000 |
| Other | ||||
| End Cash Position | $70,592,000 | $44,203,000 | $121,212,000 | $188,593,000 |
| Beginning Cash Position | $44,203,000 | $121,212,000 | $188,593,000 | $224,133,000 |
| Effect Of Exchange Rate Changes | $27,000 | $-65,000 | $13,000 | $18,000 |
| Changes In Cash | $26,362,000 | $-76,944,000 | $-67,394,000 | $-35,558,000 |
| Net Investment Purchase And Sale | $-16,207,000 | $-936,000 | $-24,355,000 | $0 |
| Sale Of Investment | $47,798,000 | $54,564,000 | $24,519,000 | $0 |
| Purchase Of Investment | $-64,005,000 | $-55,500,000 | $-48,874,000 | $0 |
| Net Business Purchase And Sale | $67,909,000 | $-44,783,000 | $0 | $-13,762,000 |
| Sale Of Business | $69,909,000 | $0 | - | - |
| Purchase Of Business | $-2,000,000 | $-44,783,000 | $0 | $-13,762,000 |
| Net PPE Purchase And Sale | $-955,000 | $-602,000 | $-2,045,000 | $-2,045,000 |
| Purchase Of PPE | $-955,000 | $-602,000 | $-2,045,000 | $-2,045,000 |
| Change In Working Capital | $-15,297,000 | $-2,542,000 | $-1,573,000 | $3,357,000 |
| Change In Other Working Capital | $-3,177,000 | $-368,000 | $179,000 | $1,892,000 |
| Change In Other Current Liabilities | $-1,662,000 | $-2,063,000 | $-1,583,000 | $-1,419,000 |
| Change In Other Current Assets | $1,934,000 | $2,606,000 | $1,533,000 | $1,133,000 |
| Change In Payables And Accrued Expense | $-5,931,000 | $2,319,000 | $2,033,000 | $452,000 |
| Change In Prepaid Assets | $-2,950,000 | $-445,000 | $-513,000 | $844,000 |
| Change In Inventory | $-3,731,000 | $-1,664,000 | $-3,902,000 | $-5,475,000 |
| Change In Receivables | $220,000 | $-2,927,000 | $680,000 | $5,930,000 |
| Changes In Account Receivables | $220,000 | $-2,927,000 | $680,000 | $5,930,000 |
| Other Non Cash Items | $13,741,000 | $-13,216,000 | $299,000 | $208,000 |
| Stock Based Compensation | $9,845,000 | $11,763,000 | $9,787,000 | $7,207,000 |
| Provisionand Write Offof Assets | $513,000 | $829,000 | $1,049,000 | $376,000 |
| Asset Impairment Charge | $0 | $40,659,000 | $0 | - |
| Amortization Of Securities | $-637,000 | $13,000 | $-301,000 | $0 |
| Deferred Tax | $0 | $-283,000 | $-305,000 | $-129,000 |
| Deferred Income Tax | $0 | $-283,000 | $-305,000 | $-129,000 |
| Depreciation Amortization Depletion | $4,465,000 | $4,682,000 | $2,384,000 | $1,614,000 |
| Depreciation And Amortization | $4,465,000 | $4,682,000 | $2,384,000 | $1,614,000 |
| Gain Loss On Sale Of PPE | $133,000 | $54,000 | $0 | - |
| Gain Loss On Sale Of Business | $-55,940,000 | $0 | - | - |
| Net Income From Continuing Operations | $19,489,000 | $-72,206,000 | $-36,399,000 | $-33,563,000 |
| Repayment Of Debt | - | $0 | $-15,000,000 | $-60,000,000 |
| Interest Paid Supplemental Data | - | $184,000 | $0 | $135,000 |
| Income Tax Paid Supplemental Data | - | $184,000 | - | - |
| Net Issuance Payments Of Debt | - | $0 | $-15,000,000 | $0 |
| Net Long Term Debt Issuance | - | $0 | $-15,000,000 | $0 |
| Long Term Debt Payments | - | $0 | $-15,000,000 | $-60,000,000 |
| Issuance Of Debt | - | - | $0 | $60,000,000 |
| Long Term Debt Issuance | - | - | $0 | $60,000,000 |
| Proceeds From Stock Option Exercised | - | - | - | - |
| Net Short Term Debt Issuance | - | - | - | - |
| Short Term Debt Payments | - | - | - | - |
| Short Term Debt Issuance | - | - | - | - |